ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315234/ |